CLPT

Clearpoint Neuro Inc

• TipRanks·08/05 06:00

  Execution Risks Loom Over Clearpoint Neuro’s CAL Preclinical CRO Investment and Future Profitability

• TipRanks·08/05 00:53

  ClearPoint Neuro Earnings Call Highlights Growth and Strain

• Seeking Alpha·08/04 21:10

  ClearPoint Neuro: Regulatory Momentum Strengthens The Long-Term Investment Case

• TipRanks·08/04 16:01

  Midday Fly By: Palantir, Caterpillar, McDonald’s report Q2 beats

• TipRanks·08/04 13:50

  Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (ORIC), ClearPoint Neuro (CLPT) and Keros Therapeutics (KROS)

• TipRanks·08/04 12:46

  ClearPoint Neuro price target lowered to $25 from $30 at Lake Street

• TipRanks·08/04 11:02

  ClearPoint Neuro price target lowered to $22 from $25 at Stifel

• TipRanks·08/03 23:05

  Closing Bell Movers: Palantir surges after quarterly report

• NASDAQ·08/03 23:00

  ClearPoint Neuro (CLPT) Reports Q2 Earnings: What Key Metrics Have to Say

• TipRanks·08/03 20:46

  ClearPoint Neuro cuts FY26 revenue view to $48M-$52M from $52M-$56M

• TipRanks·08/03 20:43

  ClearPoint Neuro Updates Q2 Results and 2026 Outlook

• TipRanks·08/03 20:40

  ClearPoint Neuro reports Q2 EPS (38c), consensus (29c)

• Seeking Alpha·08/03 20:37

  ClearPoint Neuro, Inc. GAAP EPS of -$0.38 misses by $0.09, revenue of $10.9M misses by $1.83M

• Seeking Alpha·08/03 14:00

  Here are the major earnings after the close Monday

• TipRanks·08/03 13:16

  Lake Street Sticks to Its Buy Rating for ClearPoint Neuro (CLPT)